Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The radial artery (RA) can be used as part of an arterial revascularization strategy in coronary artery bypass grafting (CABG). It is easy to harvest and several randomized controlled trials and meta-analyses have reported superior long-term patency over saphenous vein grafts. However, the RA is not used as frequently as the saphenous vein and questions remain regarding its optimum use as a conduit. This article comprehensively appraises current evidence surrounding outcomes, patient selection, harvesting technique, intraoperative strategy, and graft spasm prophylaxis to provide a contemporary review of the use of the RA as a conduit in CABG.

Original publication




Journal article


Ann Thorac Surg

Publication Date





1900 - 1909


23, BIMA, CABG, CSA, IMA, LAD, LIMA, LSV, MI, PVD, RA, RAPCO, RAPS, RCT, RSVP, Radial Artery Patency Study, Radial Artery Patency and Clinical Outcomes, Radial Artery Versus Saphenous Vein Patency, VG, bilateral internal mammary arteries, coronary artery bypass grafting, cross-sectional area, internal mammary artery, left anterior descending, left internal mammary artery, long saphenous vein, myocardial infarction, peripheral vascular disease, radial artery, randomized controlled trial, verapamil with nitroglycerin, Coronary Artery Bypass, Humans, Radial Artery, Saphenous Vein